Surgery Partners, Inc. financial data

Symbol
SGRY on Nasdaq
Location
310 Seven Springs Way, Suite 500, Brentwood, TN
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 10, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 187 % +5.89%
Quick Ratio 15.1 % +4.41%
Return On Equity -5.42 % -176%
Return On Assets -2.16 % -157%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 129M shares +1.75%
Common Stock, Shares, Outstanding 129M shares +1.49%
Entity Public Float 2.6B USD -44.7%
Weighted Average Number of Shares Outstanding, Basic 127M shares +0.82%
Weighted Average Number of Shares Outstanding, Diluted 127M shares +0.82%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense 131M USD +5.58%
Operating Income (Loss) 406M USD +25.8%
Income Tax Expense (Benefit) 125M USD +532%
Net Income (Loss) Attributable to Parent -171M USD -183%
Earnings Per Share, Basic -1 USD/shares -189%
Earnings Per Share, Diluted -1 USD/shares -189%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 203M USD -8.3%
Accounts Receivable, after Allowance for Credit Loss, Current 579M USD +6.71%
Inventory, Net 92.3M USD +12.6%
Other Assets, Current 183M USD +26.8%
Assets, Current 1.1B USD +6.41%
Deferred Income Tax Assets, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 276M USD -7.33%
Intangible Assets, Net (Excluding Goodwill) 45.7M USD -16.6%
Goodwill 5.09B USD +5.74%
Other Assets, Noncurrent 40.7M USD -0.97%
Assets 7.95B USD +5.47%
Accounts Payable, Current 175M USD +2.23%
Employee-related Liabilities, Current 69.9M USD +7.7%
Liabilities, Current 586M USD +1.88%
Long-term Debt and Lease Obligation 3.46B USD +11.8%
Deferred Income Tax Liabilities, Net 42.6M USD
Operating Lease, Liability, Noncurrent 266M USD -7.02%
Other Liabilities, Noncurrent 38.1M USD +25.7%
Accumulated Other Comprehensive Income (Loss), Net of Tax -14.4M USD -237%
Retained Earnings (Accumulated Deficit) -800M USD -27.3%
Stockholders' Equity Attributable to Parent 1.73B USD -8.81%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 3.14B USD +0.97%
Liabilities and Equity 7.95B USD +5.47%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 6M USD -85.3%
Net Cash Provided by (Used in) Financing Activities 30.2M USD -4.73%
Net Cash Provided by (Used in) Investing Activities -76.4M USD +8.06%
Common Stock, Shares Authorized 300M shares 0%
Common Stock, Shares, Issued 129M shares +1.49%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -40.2M USD -276%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 203M USD -8.3%
Deferred Tax Assets, Valuation Allowance 285M USD +89.7%
Deferred Tax Assets, Gross 404M USD +5.65%
Operating Lease, Liability 308M USD -6.16%
Payments to Acquire Property, Plant, and Equipment 22.7M USD +8.1%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -196M USD -54.4%
Lessee, Operating Lease, Liability, to be Paid 485M USD +18.5%
Operating Lease, Liability, Current 41.3M USD -0.24%
Lessee, Operating Lease, Liability, to be Paid, Year Two 62.3M USD +14.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 65.2M USD +10.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) -300K USD -112%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 152M USD +23.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 53.9M USD +6.52%
Deferred Tax Assets, Operating Loss Carryforwards 143M USD -0.49%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20.3M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 43.9M USD +3.05%
Operating Lease, Payments 15.8M USD +1.28%
Additional Paid in Capital 2.54B USD +1.17%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 150M USD +0.13%
Deferred Tax Assets, Net of Valuation Allowance 119M USD -48.7%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%